Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,244 citations, 2020 year and green oa status.
1,244
Citations
2020
Year
green
OA Status